Brainstorm Cell Therapeutics
Biotechnology Research
12 Bazel Street
32 employees
- Employees
- 32
- Contacts
- 4
- Emails
- 4
- Phones
- 1
Brainstorm Cell Therapeutics Overview
- Headquarters
- 12 Bazel Street
- Phone Number
- Available in AeroLeads
- Website
- brainstorm-cell.com
- Industry
- Biotechnology Research
- Employees
- 32
- Founded
- 2004
- Funding
- 4.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Brainstorm Cell Therapeutics
BrainStorm Cell Therapeutics Inc. (NASDAQ) develops autologous stem cell therapies for neurodegenerative disorders such as ALS, MS, and Parkinson’s disease. These diseases have limited treatment options and represent unmet medical needs. NurOwn® is BrainStorm’s proprietary process for differentiating autologous mesenchymal stem cells (MSC) into neurotrophic factor (NTF)-secreting cells, transplanted at or near the affected tissue site. Our technology converts MSCs into a living drug delivery system for NTFs. We have proof-of-concept in various animal models of neurodegenerative diseases, including Parkinson's, Huntington's, ALS, MS, and peripheral nerve injury. We have completed two single-arm clinical trials in ALS patients in Israel, demonstrating good safety and tolerability profiles and strong efficacy signals. We also finalized a Phase 3 randomized, double-blind, placebo-controlled clinical trial at multiple US sites, supported by a $16 million USD grant from the California Institute for Regenerative Medicine (CIRM) and another grant from the ALS Association. Currently, we are planning a Phase 3b clinical trial of NurOwn® in ALS under a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA). For more information, visit www.brainstorm-cell.com
Brainstorm Cell Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 4
- Email contacts
- 4
- 100.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Brainstorm Cell Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Haro Hartounian, Ph.d. | CEO - Board Director - C-suite | New York City Metropolitan Area, United States |
Email
Phone
|
| Mary Kay Turner | Results-oriented Leader in Life Science | New York City Metropolitan Area, United States |
Email
|
| Bob Dagher, Md | Executive Vice President & Chief | Greater Boston, United States |
Email
|
| Merav Bahat | Business Development and Project | Petah Tikva, Center District, Israel |
Email
|
Employees by Management Level
Individual contributor
6 profiles
Executive
3 profiles
Manager
3 profiles
VP / Head
1 profile
Senior / Lead
1 profile
Associate / junior
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 3 | 3 | 0 |
| Healthcare | 1 | 1 | 0 |
Brainstorm Cell Therapeutics Tech Stack
Data / AI
3 profiles
Engineering
1 profile
Compare Similar Companies to Brainstorm Cell Therapeutics
Pluri
Biotechnology Research
CytoReason
Biotechnology Research
Evogene
Biotechnology Research
MeMed
Biotechnology Research
Anima Biotech
Biotechnology Research
Clene Nanomedicine, Inc.
Pharmaceutical Manufacturing
Prilenia
Biotechnology Research
BioLineRx
Biotechnology Research
NeuroKaire (formerly Genetika+)
Biotechnology Research
NeuroSense Therapeutics
Biotechnology Research